15 research outputs found
Baseline characteristics.
<p>RUTF: ready-to-use therapeutic food. MUAC: middle-upper arm circumference.</p>a<p>Number (%).</p>b<p>mean ± SD: standard deviation.</p>c<p>mean (median, IQR: interquartile range).</p>d<p>91 patients analysed in the intervention group and 83 in the control group.</p><p>symptom in the 14 days prior to study inclusion.</p>f<p>axillary temperature >38°C.</p>g<p>3 or more liquid stools in any 24 hour period.</p>h<p>occasional persistent vomiting.</p
Mean rate of weight change (g/kg per day), stratified by breastfeeding.
a<p>Mean (95% CI) n.</p>b<p>Mean (95% CI).</p>Â¥<p>likelihood ratio test (LRT) for effect modification.</p
Mean rate of weight change (g/kg per day), stratified by sex.
a<p>Mean (95% CI) n.</p>b<p>Mean (95% CI).</p>Â¥<p>likelihood ratio test (LRT) for effect modification.</p
Reasons for permanently stopping individual drugs during MDR-TB treatment
<p>Abbreviations: E = ethambutol, Z = pyrazinamide, S = streptomycin, Km = kanamycin, Cm = capreomycin, Ofx = ofloxacin, Eto = ethionamide, Cs = cycloserine, PAS = <i>p</i>-aminosalicylic acid, Amx/Clv = amoxicillin/clavulanate, Clz = clofazamine</p
Mean weight gain (g).
a<p>mean (95% CI) SD.</p>b<p>RUTF n = 88, control n = 86.</p>c<p>RUTF n = 87, control n = 84.</p
Univariate analysis of factors potentially contributing to the outcomes of death and failure (combined) and default.
*<p><i>p</i><0.05. P values compare treatment success to death or failure, and to default, respectively.</p
Number gaining any weight (>0 g).
a<p>n (%).</p>b<p>OR (95% CI).</p>c<p>RUTF n = 88, control n = 86.</p>d<p>RUTF n = 87, control n = 84.</p
Drug resistance among 87 MDR-TB patients started on treatment.
<p>Drug resistance among 87 MDR-TB patients started on treatment.</p
Patient recruitment and outcomes from MDR-TB treatment October 2003 to January 2005.
<p>Patient recruitment and outcomes from MDR-TB treatment October 2003 to January 2005.</p